B-cell Chronic Lymphocytic Leukemia: Clinical Trials

5 trials for B-cell Chronic Lymphocytic Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 unknown, 1 terminated. 5 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 2, Unknown 2, Terminated 1

Follow B-cell Chronic Lymphocytic Leukemia: new trials by email Literature Review of B-cell Chronic Lymphocytic Leukemia trials Research Report on B-cell Chronic Lymphocytic Leukemia

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by CART19
anti-CD19-CAR vector-transduced T cells - Hematopoietic/Lymphoid Cancer, Adult Acute Lymphoblastic Leukemia in Remission
Not applicableUnknownChinese PLA General Hospital122013-04-012016-01-28
Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma
bortezomib, filgrastim, autologous hematopoietic stem cell transplantation - Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia
Not applicableCompletedBarbara Ann Karmanos Cancer Institute232011-07-012021-05-10
Lenalidomide as Chemoprevention in Treating Patients With High-Risk, Early-Stage B-Cell Chronic Lymphocytic Leukemia
lenalidomide, laboratory biomarker analysis, lymph node biopsy - B-cell Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia
Not applicableTerminatedRoswell Park Cancer Institute82010-01-012016-06-30
Low Dose Alemtuzumab for Consolidation and Maintenance of Patients With B-Cell Chronic Lymphocytic Leukemia
Alemtuzumab - B-Cell Chronic Lymphocytic Leukemia
Not applicableUnknownTawam Hospital602006-07-012006-07-25
Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer
fludarabine phosphate, total-body irradiation, nonmyeloablative allogeneic hematopoietic stem cell transplantation - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Not applicableCompletedFred Hutchinson Cancer Center551999-11-012019-09-10

Narrower conditions

Leukemia, Lymphocytic, Chronic, B-Cell (5)  ·  Lymphoma, Follicular (3)  ·  Leukemia, Hairy Cell (2)  ·  Lymphoma, B-Cell, Marginal Zone (2)  ·  Lymphoma, Large B-Cell, Diffuse (2)  ·  Lymphoma, Mantle-Cell (2)  ·  Lymphoma, Non-Hodgkin (2)  ·  Multiple Myeloma (2)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Waldenstrom Macroglobulinemia (2)  ·  Burkitt Lymphoma (1)  ·  Carcinoma, Renal Cell (1)  ·  Congenital Abnormalities (1)  ·  Hematologic Neoplasms (1)  ·  Hodgkin Disease (1)

Broader conditions

Chronic Disease (5)  ·  Disease Attributes (5)  ·  Hematologic Diseases (5)  ·  Hemic and Lymphatic Diseases (5)  ·  Immune System Diseases (5)  ·  Immunoproliferative Disorders (5)  ·  Leukemia (5)  ·  Leukemia, B-Cell (5)  ·  Leukemia, Lymphoid (5)  ·  Lymphatic Diseases (5)  ·  Lymphoproliferative Disorders (5)  ·  Neoplasms (5)  ·  Neoplasms by Histologic Type (5)  ·  Pathologic Processes (5)  ·  Pathological Conditions, Signs and Symptoms (5)

Interventions

Alemtuzumab (1)  ·  Bortezomib (1)  ·  Cyclosporine (1)  ·  Filgrastim (1)  ·  Flow Cytometry (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Lenalidomide (1)  ·  Mycophenolic Acid (1)  ·  Peripheral Blood Stem Cell Transplantation (1)  ·  Sentinel Lymph Node Biopsy (1)  ·  Transplantation (1)  ·  Whole-Body Irradiation (1)  ·  fludarabine phosphate (1)

Sponsors

Barbara Ann Karmanos Cancer Institute (1)  ·  Chinese PLA General Hospital (1)  ·  Fred Hutchinson Cancer Center (1)  ·  Roswell Park Cancer Institute (1)  ·  Tawam Hospital (1)

Countries

United States (3)  ·  China (1)  ·  Germany (1)

Top investigators

Brenda Sandmaier (1)  ·  Divaya Bhutani, M.D. (1)  ·  Jorgen Kristensen, MD PhD (1)  ·  Myron Czuczman (1)

Results publications

PMID 26451310, PMID 29599530, PMID 32499241

NIH funding

P01CA018029 (1), P30CA015704 (1), P30CA022453 (1)